Back to results
US 11,690,913 B2Granted
Combining adenovirus and checkpoint inhibitors for treating cancer
AssigneeTargovax Oy
InventorsTuuli Ranki, Sari Anneli Pesonen, Magnus Jäderberg, Elina Haavisto, Lukasz Kuryk, Antti Vuolanto
Life of this patent
Estimating the term…
Abstract
The invention relates to the combination therapy comprising oncolytic adenovirus vector and a checkpoint inhibitor or checkpoint inhibitors. More specifically, the invention relates to oncolytic adenovirus vector and checkpoint inhibitor or checkpoint inhibitors for use in a cancer therapy.
Claims18
A method of treating cancer in a human subject in need thereof, the method comprising administering ONCOS-102 adenovirus to the subject locally and administering a checkpoint inhibitor or checkpoint inhibitors to the subject systemically.
Dependencies are inferred from the claim text.